Fred Lybrand

When there are updated regulations for #emissions monitoring, we partner with our customers to help them understand how the regulations impact their operations so we can continue to provide innovative technologies that enable them to make the world healthier, cleaner and safer.   Following the updated National Emission Standards for Hazardous Air Pollutants (#NESHAP) guidelines on ethylene oxide (#EtO) set by the US #EPA, my colleague Kelly McPartland shared her insights in a Medical Design & Outsourcing article on the steps toward compliance and the solutions available for long-term resiliency.   Read the article to learn more. https://lnkd.in/ehkWxknD

53

A very nice application of #software to improve productivity in #chromatography #massspectrometry workflows by Mestrelab Research S.L. , part of the SciY family, with an excellent ROI as proven already by early adopter use cases #labautomation #laboratoryautomation #drugdiscovery #drugdevelopment

12

Olaf Stamm discusses key criteria to consider when establishing analytical studies for a biosimilar drug candidate to ensure its safety, efficacy, and similarity compared to the reference product in the this article. Discover more here: https://bit.ly/3XnHA0D

23

Our CLEAR series is gaining attention for its energy-saving performance. It's worth exploring. Get informed!

10

Come and watch our latest webinar to learn more about Mabion and why we are your CDMO of choice! #CDMO #Mabion

7

https://lnkd.in/ggRMWiJi Gross microbiological contamination but we wait almost a year to warn you? What happened to all those drugs made before, during and after the inspection that captured the evidence of gross contamination? These and many more questions paint a picture of why the agency even bothers to issue Warning Letters almost a year after the inspection that show significant risk to the consumer. This Warning Letter belongs to the latest batch just released by the agency, so it shows the current state of risk monitoring and mitigation. Not much urgency and not much mitigation, but much exposure. The best we can hope for, the gross current FDA recall process to kick in.

8

3 Comments

Wondering how you will navigate the new FDA stance on LDTs? We are here to discuss strategies and paths to success. Contact i5 BioPartners to learn more.

11

1 Comment

On my way to Boston for the LNP Formulation & Process Development Summit this week! Excited to connect with industry leaders and learn more about the current state of the LNP field. If you are attending the conference and are interested in discussing how Upkara's novel stabilization technology can be leveraged to produce LNPs that are stable at ambient temperatures and address your LNP formulation and manufacturing challenges then let's chat! #stabilizingscience, #LNP

16

1 Comment

It's #BuzzTechTuesday! Did you know Georgia Institute of Technology's new nanofiltration membrane removes CECs while also recovering valuable nutrients? It's a custom high-performance separation membrane that can be used in water purification, water reuse, and resource recovery to positively impact our health as well as the environment. Read about it! https://ow.ly/jiWf50Rk9OA

9

There are so many advantages of the co-located lab and clinic that we offer in Lincoln. From the scientific advantage such as PBMC prep, Flow Cytometry and rapid sample analysis to the cost and risk savings of eliminating sample shipment to the improved ease of business by having a one stop shop for your Phase 1 and other Clin Pharm studies with one contract, one site to visit and a single point of contact who can get EVERYONE running a study in the same room. This just can’t happen anywhere else. The analysis is literally one staircase away from the clinic processing lab. Not only that, for your bioanalytical needs we will conduct all of your assays in the same building: safety labs, PK LCMS/LBS, Flow cytometry, biomarkers or qPCR. Give us a call for your next study! #celerion #celerionbioanalysis

40

Excellent approach outlined here by, Provia. Reliable benchmarking in early phases of a project/program is critical for many reasons and can be remarkably challenging to come by.

1

1 Comment

Empowering Biotech Innovations at GPC Bio At GPC Bio, we don't just ask "What do you need?"—we ask "What do you do?" This unique approach allows us to tailor our scientific expertise and cutting-edge technology specifically to your goals in lab equipment or scaling-up. Why Choose Us? - Tailored Solutions: We dive deep into your processes, from fermentation to cell culture, to design and optimize your operations for scalability. - Expertise & Innovation: Our team of scientists and engineers doesn't just build pilot scale equipment; we design and optimize entire facilities. - Collaborative Approach: We believe in working hand-in-hand with you to enhance process efficiencies and achieve commercial success. Ready to Scale Up your lab ? Visit us at www.gpc-bio.com to learn how we can support your growth aspirations. #Biotech, #Innovation, #ScaleUp, #Fermentation, #CellCulture, #Biotechnology, #ScientificExcellence, #GPCBio, #LifeSciences, #ProcessOptimization, #faccne

16

1 Comment

Centrifugation is a method of separating particles commonly used in laboratories 5 Tips for Better Centrifugation Select the Appropriate Rotor Use the Appropriate Tube Balance the Centrifuge Determine the Appropriate Speed Secure the Rotor Lid To Learn more about Corning LifeScience solutions for #centrifugation connect with Acube Lab Solutions https://lnkd.in/dqcZpMdX

13

If you gave the same molecule to two different companies before Phase 1, would they be equally successful? I'll explain why the answer is "No" during my talk next Thursday at the ISPE Greater Los Angeles Area Chapter Vendor Night Technical Session, and also covering the impact AI/ML is having on Drug Development. Register for the event here if you haven't already! Information can be found in the link below, and also credit to IDEA Pharma on the thought-provoking question.

40

4 Comments

Join the Alcami experts to hear them speak about critical GMP materials storage and management.

3

Let’s talk about the progress of the new facility and opportunities with open slots for fills in 2024. In a pinch? let’s make it happen!

32